Globe Newswire Company plans to launch multiple direct-from-blood diagnostics over the next 15 months for antimicrobial resistance, pediatric Candida infections, Lyme disease, and Candida aurisLEXINGTON, Mass...\n more…
Ticker Report T2 Biosystems, Inc. (NASDAQ:TTOO - Get Free Report) shares passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $4.27 and traded as low as...\n more…
Globe Newswire LEXINGTON, Mass., Aug. 27, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...\n more…
Ticker Report T2 Biosystems, Inc. (NASDAQ:TTOO - Get Free Report)'s share price passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $4.49 and traded as low...\n more…